Midostaurin demonstrated a statistically significant improvement in overall survival among AML patients.
Hematology
Latest News
Advertisement
CME Content
Advertisement
Midostaurin (Rydapt) approved to treat acute FLT3 mutation positive acute myeloid leukemia.
Stivarga expanded to include the treatment of hepatocellular carcinoma in patients previously treated with sorafenib.
Stivarga is the first FDA-approved treatment for hepatocellular carcinoma in almost a decade.
Top news of the week in oncology and cancer drug development.
Findings could help improve treatment efficacy for patients with ALL.
Multiple myeloma survivor seeks to empower patients by illustrating the value of human life.
Protein determines whether breast cancer cells become resistant to tamoxifen.
The activation of the STAT5 protein linked to acute lymphoblastic leukemia.
Polymer capsules that could play a key role in delivering targeted cancer therapies.
Top news of the week in oncology and cancer drug development.
Top news of the week in oncology and cancer drug development.
Hodgkin lymphoma cancer survivors are 2.4 times more likely to develop a second type of cancer.
Study identifies potential Achilles heel of kinase-driven cancers.
Treatment with endostatin slowed the proliferation of resistant prostate cancer cells.
Most models were cancer-free within 6 weeks of treatment with selenomab-drug conjugates.
Next-generation antibody treatments effectively deliver cytotoxic drugs to tumors.
Corticosteroids, chemotherapy, and immunotherapy may all be used to treat castration-resistant prostate cancer.
Top news of the week in oncology and cancer drug development.
Checkpoint inhibitors plus myeloid-derived suppressor cell inhibitors show promise as prostate cancer treatment.
Quiescent stem cells are dormant and are not impacted by cancer treatments.
The addition of abemaciclib to fulvestrant appeared to effectively improve progression-free survival in patients with breast cancer.
The addition of abemaciclib to fulvestrant appeared to effectively improve progression-free survival.
High yogurt intake may protect against breast cancer, while processed cheeses may increase cancer risk.
Mapping lung cancer cell interactions can unveil new targeted treatment techniques.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Beyond Off-Label: How Auvelity's Approval Changes Agitation Management in Alzheimer Disease
2
GLP-1s May Curb Lung Fibrosis in Diabetes, Long COVID
3
Translation: A Pharmacist’s Greatest Skill
4
What Does the FDA Advisory Committee’s Vote on 7 Peptides Mean for Pharmacy Practice?
5